Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$97.82 - $116.09 $457,308 - $542,720
-4,675 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$97.62 - $120.59 $361,486 - $446,544
-3,703 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $639,623 - $715,316
-6,669 Reduced 64.3%
3,703 $366,000
Q4 2017

Feb 14, 2018

BUY
$104.5 - $126.38 $1.08 Million - $1.31 Million
10,372
10,372 $1.09 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.